Breaking News
SPLC 'Fascism Expert' Funneled $1.2 MILLION in Donor Cash to Her Neo-Nazi Informant/Lover
Israeli Ministers Say Israel Isn't Bound by US-Iran Deal, Won't Withdraw From Lebanon
EXCLUSIVE: Top FBI Whistleblower Says The Supposed Terror Plot Targeting The White House...
Heterofatalism
Top Tech News
Heads up: Apparently the government is hiding cameras inside fake utility boxes
Sodium Batteries And EVs That Power The Grid: Inside GM's Big Energy Push
NUCLEAR ENGINE - UNLIMITED LUXURY - 20 YEARS WITHOUT REFUELING
China Unveils Nuclear-Powered Floating Hub For Green Shipping
China Launches World's 1st Commercial Brain Chip, Beating Elon Musk's Neuralink!
Modular next-gen US nuclear reactor goes critical
How EMF's cause disease
This Company Will Add Phone, AirPod, and Smartwatch Trackers to License Plate Readers
Elon Details SpaceX AI Data Center in Space Details and Roadmap
5-in-1 miniature surgical robot is the size of a seed 
Pathway to radical longevity – Induced Tissue Regeneration explained
Full regeneration and immortalized cells exists in humans two weeks after conception.
There is work to re-activate those capabilities with adult cells.
The video and screenshots below are from the the CEO of AgeX Dr Michael West and another with Michael West talking with Dr. Aubrey de Grey, V.P. New Technology Discovery.
AgeX Therapeutics is a biotechnology company formed in 2017 as a subsidiary of BioTime, Inc (NYSE MKT: BTX). Its mission is to apply technology related to cell immortality and pluripotency to human aging and age-related disease. The Company's technology platform has three facets: Pluripotent stem cell-derived progenitor cell lines representing over 200 types of cells in the body (PureStem technology); HyStem matrices; and induced tissue regeneration (iTR) – the latter being an emerging technology directed at inducing the immortal regeneration of tissues in the body.